Status: Recruiting
Using ctDNA to Determine Therapies for Lung Cancer
This is a study to look at whether the presence of circulating tumour DNA (ctDNA) in the blood can help to predict whether giving adjuvant treatment after surgery can decrease the chance of the cancer coming back in people with lung cancer.
Participants needed: 66
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: University Health Network, TorontoUpdated: Dec 18, 2025Locations: 1
Eligibility criteria
Age ≥ 18 years at the time of screening [+11]
Participants that should receive adjuvant chemotherapy per standard of care (res... [+25]